![]() |
|
|
A more recent version of this article appeared on November 1, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 15, 2006
Revised on July 24, 2007
Accepted on August 8, 2007
*School of Biological and Biomedical Sciences, Durham University, Durham DH1 3LE, United Kingdom;
School of Clinical Medical Sciences (Gerontology), Henry Wellcome Laboratory for Biogerontology Research, Newcastle General Hospital, Newcastle upon Tyne NE4 6BE, United Kingdom;
Protein Design Group, Department of Biochemistry, School of Life Sciences, University of Sussex, Falmer, BN1 9QG, United Kingdom;
Centre for High Resolution Imaging and Processing, University of Dundee, Dundee DD1 5LE, United Kingdom
Monitoring Editor: M. Bishr Omary
The lens is an avascular tissue, separated from the aqueous and vitreous humors by its own extracellular matrix, the lens capsule. Here we demonstrate that the lens capsule is a source of essential survival factors for lens epithelial cells. Primary and immortalised lens epithelial cells survive in low levels of serum and are resistant to staurosporine-induced apoptosis when they remain in contact with the lens capsule. Physical contact with the capsule is required for maximal resistance to stress. The lens capsule is also a source of soluble factors including FGF-2 and perlecan, an ECM component that enhances FGF-2 activity. MMP-2 inhibition as well as MMP-2 pre-treatment of lens capsules greatly reduced the protective effect of the lens capsule, although this could be largely reversed by the addition of either conditioned medium or recombinant FGF-2. These data suggest that FGF-2 release from the lens capsule by MMP-2 is essential to lens epithelial cell viability and survival.
This article has been cited by other articles:
![]() |
M. Saint-Geniez, T. Kurihara, and P. A. D'Amore Role of Cell and Matrix-Bound VEGF Isoforms in Lens Development Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 311 - 321. [Abstract] [Full Text] [PDF] |
||||